PAA
MRNA icon

Peregrine Asset Advisers’s Moderna MRNA Stock Holding History

Peregrine Asset Advisers’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,376
Closed -$837K – 145
2021
Q3 		$837K Buy
2,376
+131
+6% +$48.3K 0.43% 53
2021
Q2 		$528K Buy
2,245
+245
+12% +$43.8K 0.24% 65
2021
Q1 		$262K Hold
2,000
– – 0.13% 86
2020
Q4 		$209K Buy
+2,000
New +$202K 0.1% 122

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Peregrine Asset Advisers's MRNA Position: Q4 2021 in Review

Peregrine Asset Advisers sold out of Moderna (MRNA) in Q4 2021, closing a stake of 2,376 shares — an estimated $837K sold.

Peregrine Asset Advisers first reported a position in MRNA in Q4 2020 and held it in 4 quarters. The position peaked at $837K in Q3 2021. 1,109 funds tracked by Wall St. Rank hold MRNA as of Q4 2021.

  • Peregrine Asset Advisers reported no remaining Moderna position as of Q4 2021 after selling out during the quarter.
  • Peregrine Asset Advisers sold 2,376 Moderna shares in Q4 2021, an estimated $837K.
  • Peregrine Asset Advisers first reported a position in Moderna in Q4 2020 and held it in 4 quarters.
  • Peregrine Asset Advisers's Moderna position peaked at $837K in Q3 2021.
  • 1,109 funds tracked by Wall St. Rank held Moderna as of Q4 2021.

Based on Peregrine Asset Advisers's 13F filing for Q4 2021, filed 9 Feb 2022.